HER2 expression status in diverse cancers: review of results from 37,992 patients von Yan, Min, Schwaederle, Maria, Arguello, David, Millis, Sherri Z., Gatalica, Zoran, Kurzrock, Razelle

Volltext

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma von Gounder, Mrinal M., Agaram, Narasimhan P., Trabucco, Sally E., Robinson, Victoria, Ferraro, Richard A., Millis, Sherri Z., Krishnan, Anita, Lee, Jessica, Attia, Steven, Abida, Wassim, Drilon, Alexander, Chi, Ping, Angelo, Sandra P. D’, Dickson, Mark A., Keohan, Mary Lou, Kelly, Ciara M., Agulnik, Mark, Chawla, Sant P., Choy, Edwin, Chugh, Rashmi, Meyer, Christian F., Myer, Parvathi A., Moore, Jessica L., Okimoto, Ross A., Pollock, Raphael E., Ravi, Vinod, Singh, Arun S., Somaiah, Neeta, Wagner, Andrew J., Healey, John H., Frampton, Garrett M., Venstrom, Jeffrey M., Ross, Jeffrey S., Ladanyi, Marc, Singer, Samuel, Brennan, Murray F., Schwartz, Gary K., Lazar, Alexander J., Thomas, David M., Maki, Robert G., Tap, William D., Ali, Siraj M., Jin, Dexter X.

Volltext

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities von Millis, Sherri Z., Jardim, Denis L., Albacker, Lee, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Kurzrock, Razelle

Volltext

BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma von Seligson, Nathan D., Kautto, Esko A., Passen, Edward N., Stets, Colin, Toland, Amanda E., Millis, Sherri Z., Meyer, Christian F., Hays, John L., Chen, James L.

Volltext

Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets von Movva, Sujana, Wen, Wenhsiang, Chen, Wangjuh, Millis, Sherri Z, Gatalica, Zoran, Reddy, Sandeep, von Mehren, Margaret, Van Tine, Brian A

Volltext

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1 von Gatalica, Zoran, Bilalovic, Nurija, Palazzo, Juan P, Bender, Ryan P, Swensen, Jeffrey, Millis, Sherri Z, Vranic, Semir, Von Hoff, Daniel, Arceci, Robert J

Volltext

Prevalence of Homologous Recombination Pathway Gene Mutations in Melanoma: Rationale for a New Targeted Therapeutic Approach von Kim, Kevin B., Soroceanu, Liliana, de Semir, David, Millis, Sherri Z., Ross, Jeffrey, Vosoughi, Elham, Dar, Altaf A., Nosrati, Mehdi, Desprez, Pierre-Yves, Ice, Ryan, Chen, Michelle, Chetal, Kashish, Bhattacharjee, Anukana, Moretto, John, Leong, Stanley P., Singer, Mark I., Parrett, Brian M., Minor, David R., McAllister, Sean, Miller, James R., Salomonis, Nathan, Kashani-Sabet, Mohammed

Volltext

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma von Bill, Kate Lynn J., Seligson, Nathan D., Hays, John L., Awasthi, Achal, Demoret, Bryce, Stets, Colin W., Duggan, Megan C., Bupathi, Manojkumar, Brock, Guy N., Millis, Sherri Z., Shakya, Reena, Timmers, Cynthia D., Wakely, Paul E., Pollock, Raphael E., Chen, James L.

Volltext

Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability von Bieg-Bourne, Cheyennedra C, Millis, Sherri Z, Piccioni, David E, Fanta, Paul T, Goldberg, Michael E, Chmielecki, Juliann, Parker, Barbara A, Kurzrock, Razelle

Volltext

Recurrent secondary genomic alterations in desmoplastic small round cell tumors von Chow, Warren A., Yee, Jiing-Kuan, Tsark, Walter, Wu, Xiwei, Qin, Hanjun, Guan, Min, Ross, Jeffrey S., Ali, Siraj M., Millis, Sherri Z.

Volltext

Gene partners of the EWSR1 fusion may represent molecularly distinct entities von Walker, Victoria, Jin, Dexter X., Millis, Sherri Z., Nasri, Elham, Corao-Uribe, Diana A., Tan, Aik Choon, Fridley, Brooke L., Chen, James L., Seligson, Nathan D.

Volltext

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target von Seligson, Nathan D., Maradiaga, Richard D., Stets, Colin M., Katzenstein, Howard M., Millis, Sherri Z., Rogers, Alan, Hays, John L., Chen, James L.

Volltext

Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas von Seligson, Nathan D., Tang, Joy, Jin, Dexter X., Bennett, Monica P., Elvin, Julia A., Graim, Kiley, Hays, John L., Millis, Sherri Z., Miles, Wayne O., Chen, James L.

Volltext

Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review von Borazanci, Erkut, Millis, Sherri Z, Korn, Ron, Han, Haiyong, Whatcott, Clifford J, Gatalica, Zoran, Barrett, Michael T, Cridebring, Derek, Von Hoff, Daniel D

Volltext

Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation von Ang, Celina, Stollman, Aryeh, Zhu, Hongfa, Sarpel, Umut, Scarborough, Bethann, Sahni, Gagan, Millis, Sherri Z.

Volltext

Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy von Necchi, Andrea, Bratslavsky, Gennady, Corona, Robert J., Chung, Jon H., Millis, Sherri Z., Elvin, Julia A., Vergilio, Jo-Anne, Suh, James, Ramkissoon, Shakti, Severson, Eric, Daniel, Sugganth, Killian, Jonathan K., Ali, Siraj M., Schrock, Alexa B., Reddy, Prasanth, Miller, Vincent A., Welsh, Allison, Gay, Laurie M., Ross, Jeffrey S.

Volltext

Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine von Jiao, Guan-Sheng, Cregar, Lynne, Wang, Jinzhi, Millis, Sherri Z, Tang, Cho, O'Malley, Sean, Johnson, Alan T, Sareth, Sina, Larson, Jason, Thomas, Gary

Volltext

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma von Ang, Celina, Klempner, Samuel J, Ali, Siraj M, Madison, Russell, Ross, Jeffrey S, Severson, Eric A, Fabrizio, David, Goodman, Aaron, Kurzrock, Razelle, Suh, James, Millis, Sherri Z

Volltext

Metastatic Extramammary Paget’s Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of t... von Wong, Yu-Ning, Millis, Sherri Z., Edwards, Kristin, Dulaimi Al-Saleem, Essel, Barth, Peter, Geynisman, Daniel M.

Volltext

Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications von Millis, Sherri Z, Gatalica, Zoran, Winkler, Josiah, Vranic, Semir, Kimbrough, Jeffery, Reddy, Sandeep, O'Shaughnessy, Joyce A

Volltext